Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus POTASSIUM ACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM GLUCEPTATE versus POTASSIUM ACETATE.
CALCIUM GLUCEPTATE vs POTASSIUM ACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium gluceptate is a calcium salt that dissociates to provide calcium ions, which are essential for various physiological processes including nerve conduction, muscle contraction, blood coagulation, and cardiac function. It acts as a calcium replenisher.
Potassium acetate provides potassium ions, which are essential for maintaining intracellular ionic balance, nerve conduction, muscle contraction, and acid-base equilibrium. It acts as a potassium replenisher and can also be used to alkalinize urine by converting to bicarbonate.
IV: 2-4 mg/kg elemental calcium (5-10 mL of 0.45 mEq/mL solution) administered slowly over 10-20 minutes. May repeat if needed. Maximum dose: 20 mL per infusion.
Intravenous, 10-20 mEq/h, maximum infusion rate 20 mEq/h, not to exceed 150 mEq/day.
None Documented
None Documented
Terminal elimination half-life: 2-4 hours (normal renal function); prolonged to 12-24 hours in renal impairment.
Not applicable as potassium is not eliminated by first-order kinetics; plasma concentration reflects body stores and renal function.
Renal: >90% excreted unchanged in urine. Biliary/fecal: <5%.
Primarily renal (>90%) as potassium ions; minimal biliary/fecal.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement